Methylprednisolone inhibition of TNF-α expression and NF-κB activation after spinal cord injury in rats

Molecular Brain Research

Volumn 59, Issue 2, 1998, Pages 135-142

  Xu, Jan ^a   Fan, Guangshun ^a   Chen, Shawei ^a   Wu, Yingji ^a   Xu, Xiao Ming ^b   Hsu, Chung Y ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Gene expression; Inflammation; Secondary injury; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; SPINAL CORD INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AXONS; FEMALE; GENE EXPRESSION; METHYLPREDNISOLONE; NEURONS; NF-KAPPA B; PROTEIN BINDING; RATS; RATS, LONG-EVANS; SPINAL CORD INJURIES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032584936     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00142-9     Document Type: Article

References (58)

1. An G., Lin T.N., Liu J.S., He Y.Y., Xue J.J., Hsu C.Y. Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann. Neurol. 33:1993;457-464.
2. Anderson D.K., Braughler J.M., Hall E.D. Effects of treatment with U74006 F on neurological recovery following experimental spinal cord injury. J. Neurosurg. 69:1988;562-567.
3. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids, inhibition of NF-kB activity through induction of IkB synthesis. Science. 270:1995;286-290.
4. Baeuerle P.A., Henkel T. Functional activation of NF-kB in immune system. Am. Rev. Immunol. 12:1994;141-179.
5. Balentine J.D. Pathology of experimental spinal cord trauma. Lab. Invest. 39:1978;236-266.
6. Balentine J.D. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab. Invest. 39:1978;236-253.
7. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse, an in situ hybridization study, Europe. J. Neurosci. 9:1997;1422-1438.
8. Bartholdi D., Schwab M.E. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672:1995;177-186.
9. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139:1996;244-256.
10. Blight A.R., Cohen T.I., Saito K., Heyes M.P. Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain. 118:1995;735-752.
11. Blight A.R. Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma. 9:1992;S83-91. [Review].
12. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., Eisenberg H.M.et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. NEJM. 322:1990;1405-1461.
13. +)-ATPase, lipid peroxidation, and alpha motor neuron function. J. Neurosurg. 56:1982;838-844.
14. Buttini M., Appel K., Sauter H.W., Gebicke-Haerter P.J., Boddeke H. Expression of tumor necrosis factor alpha after focal ischemia in the rat. Neuroscience. 71:1996;1-16.
15. Caldenhoven E., Liden J., Wissink S., Stolpe A.V., Raaijmakers J., Koenderman L., Okret S., Gustafsson J.A., Saag P.T.V. Negative cross-talk between RelA and the glucocorticoid receptor, a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9:1995;401-412.
16. Chen A., Xu X.M., Kleitman N., Bunge M.B. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord. Exp. Neurol. 138:1996;261-276.
17. Clements J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., Little S.P. Global ischemia activates nuclear factor-kB in forebrain neurons of rats. Stroke. 28:1997;1073-1081.
18. Constantini S., Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80:1994;97-111.
19. Demediuk P., Saunders R.D., Anderson D.K., Means E.D., Horrocks L.A. Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc. Natl. Acad. Sci. 82:1985;7071-7075.
20. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6:1994;712-724.
21. Fujiki M., Zhang Z.Y., Guth L., Steward O. Genetic influences on cellular reactions to spinal cord injury - activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (wld(s)) that causes delayed Wallerian degeneration. J. Comp. Neurol. 371:1996;469-484.
22. L.A. Ghodosh, Mobility shift DNA binding assay using gel electrophoresis, in: F. Ausubel. R. Brent, R.E. Kingston et al. (Eds.), Current Protocols in Molecular Biology, Greene Publishing, New York, 1989, pp. 12.2-12.7.
23. Grell M., Zimmermann G., Hulser D., Pfizenmaier K., Scheurich P. TNF receptor TR 60 and TR80 can mediate apoptosis via induction of distinct signal pathway. J. Immunol. 153:1994;1963-1972.
24. Griffiths I.R., Burns N., Crawford A.R. Early vascular changes in the spinal gray matter following impact injury. Acta Neuropathol. 41:1978;33-39.
25. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma. 9:1992;123-126.
26. Hall E.D., Braughler J.M. Glucocorticoid mechanisms in acute spinal cord injury, a review and therapeutic rationale. Surg. Neurol. 18:1982;320-327.
27. Hamada Y., Ikata T., Katoh S., Nakauchi K.J., Niwa M., Kawai Y., Fukuzawa K.J. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J. Neurochem. 6:1996;1525-1531.
28. Hill G.E., Alonso A., Spurzem J.R., Stammers A.H., Robbins R.A. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J. Thorac. Cardiovasc. Surg. 110:1995;1658-1662.
29. Holets V.R., Hakfelt T., Ude J., Eckert M., Penzlin H., Verhoftsad A.A.J., Visser T.J. A comparative study of the immunohistochemical localization of a presumptive proctolin-like peptide, thyrotropin-releasing hormone and 5-hydroxytryptamine in the rat central nervous system. Brain Res. 408:1987;141-153.
30. Hsu C.Y., Dimitrijevic M.R. Methylprednisolone in spinal cord injury, the possible mechanism of action. J. Neurotrauma. 7:1990;115-119.
31. C.Y. Hsu, K. Doster, Z.Y. Hu, Cell-mediated injury, in: K. Narayan, J.E. Wilberger Jr., P.T. Polishock (Eds.), Neurotrauma: A Comprehensive Textbook of Head and Spinal Cord injury, McGraw-Hill, St. Louis, MO, 1996, pp. 1433-1444.
32. Hsu C.Y., Halushka P.V., Hogan E.L., Banik N.L., Lee W.A.et al. Alternation of thromboxane and prostacylin levels in experimental spinal cord injury. Neurology. 35:1985;1003-1009.
33. Hsu C.Y., Halushka P.V., Hogan E.L., Cox R.D. Increased thromboxane level in experimental spinal cord injury. J. Neurol. Sci. 74:1986;289-296.
34. Hsu C.Y., Halushka P.V., Spicer K.M., Hogan E.L., Martin H.F. Temporal profile of thromboxane-prostacyclin imbalance in experimental spinal cord injury. J. Neurol. Sci. 83:1988;55-62.
35. Hsu C.Y., Hogan E.L., Gadsden R.H. Sr., Spicer K.M., Shi M.P., Cox R.D. Vascular permeability in experimental spinal cord injury. J. Neurol. Sci. 70:1985;275-282.
36. Ikeda K., Nagasawa K., Horiuchi T., Tsuru T., Nishizaka H., Niho Y. C5a induces tissue factor activity on endothelial cells. Thromb. Haemost. 77:1997;394-398.
37. Kiberd B.A., Young I.D. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide. J. Lab. Clin. Med. 124:1994;496-506.
38. Lenardo M.J., Baltimore D. NF-kB, a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
39. Lippert U., Welker P., Kruger-Krasagakes S., Moller A., Henz B.M. Modulation of in vitro cytokine release from human leudemic mast cells by glucocorticoids. Skin Pharmacol. 9:1996;93-98.
40. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor alpha expression in ischemic neurons. Stroke. 25:1994;1481-1488.
41. Liu X.Z., Xu X.M., Hu R., Du C., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17:1997;5395-5406.
42. Means E.D., Anderson D.K., Waters T.R., Kalaf L. Effect of methylprednisolone in compression trauma to the feline spinal cord. J. Neurosurg. 55:1981;200-208.
43. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. J. Biol. Chem. 269:1994;13289-13295.
44. Popovich P.G., Stokes B.T., Whitacre C.C. Concept of autoimmunity following spinal cord injury - possible roles for t lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45:1996;349-363. [review].
45. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comparative Neurol. 377:1997;443-464.
46. Rothwell N.J., Luheshi G., Toulmond S. Cytokines and their receptors in the central nervous system - physiology, pharmacology, and pathology. Pharmacology and Therapeutics. 69:1996;85-95. [Review].
47. Salminen A., Liu P.K., Hsu C.Y. Alteration of transcription factor binding activities in the ischemic brain. Biochem. Biophys. Res. Commun. 212:1995;939-944.
48. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., Baldwin A.S. Jr. Characterization of mechanism involved in transrepression of NF-kB by activated glucocorticoid receptors. Mol. Cell Biol. 15:1995;943-953.
49. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor kappa B, an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radical Res. Comm. 17:1992;221-237.
50. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
51. Wagner F.C. Jr., Stewart W.B. Effect of trauma dose on spinal cord edema. J. Neurosurg. 54:1981;802-806.
52. Wang C.X., Nuttin B., Heremans H., Dom R., Gybels J. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J. Neuroimmunol. 69:1996;151-156.
53. Xu J., Wu J., He L.M., Yang Y., Moore S.A., Hsu C.Y. Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem. Biophys. Res. Commun. 235:1997;394-397.
54. Xu J., Liu T.H., Hogan E.L., Perot P.L., Hsu C.Y. Leukotriene B4 and polymorphonuclear cell infiltration in spinal cord injury. J. Neurochem. 55:1990;907-912.
55. Xu J., Qu Z.H., Cox R.D., Hogan E.L., Perot P.L. Effect of methylprednisolone on vascular permeability on rat spinal cord injury. J. Neurotrauma. 9:1992;245-253.
56. Yakovlev A.G., Faden A.I. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin gene in spinal cord following experimental traumatic injury. Mol. Chem. Neuropathol. 23:1994;179-190.
57. Young W., Flamm E.S. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J. Neurosurg. 57:1982;667-673.
58. Zhang Z.Y., Fujiki M., Guth L., Steward O. Genetic influences on cellular reactions to spinal cord injury - a wound-healing response present in normal mice is impaired in mice carrying a mutation (wld(s)) that causes delayed wallerian degeneration. J. Comparative Neurol. 371:1996;485-495.